Back to announcement
20260114_LABS_Laporan Penggunaan Dana Hasil Penawaran Umum_32020143.pdf
Other Text extracted LABSSource file signed link, expires in 15 minutes
Extracted text 6
Page 1
Go To English Page
Nomor Surat 01.006/CS-MM/LABS/I/26
Nama Perusahaan PT UBC Medical Indonesia Tbk
Kode Emiten LABS
Lampiran 1
Perihal Laporan Penggunaan Dana Hasil Penawaran Umum
Dana yang diperoleh dari Penawaran Umum IDR
Rencana Realisasi
Jumlah
Biaya Hasil Penggunaa Penggunaa
Hasil
Jenis Penawaran Realisasi n Dana n Dana Sisa Dana
Tanggal Penawaran
Penawaran Nama Emisi Umum Bersih Menurut Menurut (satuan
Efektif Umum
Umum (satuan mata (satuan Prospektus Prospektus mata uang)
(satuan
uang) mata uang) (satuan (satuan
mata uang)
mata uang) mata uang)
71.400.000.0 3.256.316.54 68.143.683.4 68.143.683.4 68.143.683.4
IPO Saham LABS 10 Juli 2024 0
00 3 57 57 57
Penempatan Sisa Dana
Jenis
Kode Nama
Penawaran Penempatan List
Efek
Umum
Sisa Dana Hubungan
Tingkat Bunga/ Jangka Waktu
(satuan mata Penempatan dengan
Bagi Hasil Penyimpanan
IPO Saham LABS uang) Perusahaan
rekening
14.205.119.400 1,9 % 0 pihak Tiga
operasional
Rincian Rencana Penawaran Umum
Jenis
Kode Nama
Penawaran Tanggal Efektif Rencana List
Efek
Umum
Hasil
Realisasi Jumlah
Bersih Uraian (satuan mata Persentase
(satuan mata uang)
uang)
IPO Saham LABS 10 Juli 2024 pembayaran 13,1700000
13.628.736.691 8.977.862.001 %
pinjaman 76293945
pembayaran 23,6800003
16.139.294.459 16.139.294.459 %
supplier lokal 0517578
pembayaran
42,2999992
28.821.407.557 supplier luar 28.821.407.557 %
3706055
negeri
Page 2
Rincian Realisasi Penawaran Umum
Jenis
Kode Nama
Penawaran Tanggal Efektif Realisasi List
Efek
Umum
Hasil
Realisasi Jumlah
Bersih Uraian (satuan mata Persentase
(satuan mata uang)
uang)
pembayaran 19,229999
IPO Saham LABS 10 Juli 2024 68.143.683.457 13.104.531.025 %
pinjaman 542236328
pembayaran 19,950000
68.143.683.457 13.593.181.744 %
supplier lokal 762939453
pembayaran
60,819999
68.143.683.457 supplier luar 41.445.970.688 %
69482422
negeri
Rincian Biaya Penawaran Umum
Jenis Jumlah Jumlah
Tanggal Persenta
Penawaran Kode Efek Hasil Uraian (Satuan Mata
Efektif se
Umum Penawaran Uang)
IPO Saham LABS 10 Juli 2024 71.400.000.000a. biaya jasa penjaminan
(underwriting fee);
1.600.094.200 2,24 %
b. biaya jasa
penyelenggaraan
0 0 %
(management fee);
c. biaya jasa penjualan
(selling fee);
0 0 %
d. biaya jasa profesi
penunjang pasar modal;
1.120.500.000 1,58 %
e. biaya jasa lembaga
penunjang pasar modal;
370.708.333 0,52 %
dan
f. biaya jasa konsultasi
keuangan (financial
0 0 %
advisory fee).
g. Biaya lain-lain yang
dapat diatribusikan
165.014.010 0,23 %
langsung sebagai biaya
emisi***)
Demikian untuk diketahui.
Hormat Kami,
PT UBC Medical Indonesia Tbk
Franciscus Xaverius Yoshua Raintjung
Direktur Utama
Page 3
PT UBC Medical Indonesia Tbk
Kawasan Industri Pulogadung, Jl. Rawa Gelam V, Blok L, No Kav 11-13, Kel.
Telepon : 021-38865110, Fax : , www.ubcindonesia.com
Nama Pengirim Franciscus Xaverius Yoshua Raintjung
Jabatan Direktur Utama
Tanggal dan Waktu 14-01-2026 23:30
Lampiran 1. LABS_Laporan Penggunaan Dana IPO 31 Des 2025.pdf
Dokumen ini merupakan dokumen resmi PT UBC Medical Indonesia Tbk yang tidak memerlukan tanda tangan
karena dihasilkan secara elektronik oleh sistem pelaporan elektronik. PT UBC Medical Indonesia Tbk bertanggung
jawab penuh atas informasi yang tertera didalam dokumen ini.
Page 4
Go To Indonesian Page
Announcement Number 01.006/CS-MM/LABS/I/26
Issuer Name PT UBC Medical Indonesia Tbk
Issuer Code LABS
Attachment 1
Subject Laporan Penggunaan Dana Hasil Penawaran Umum
Fund received form the public offering IDR
Amount of Plan for use Realized
Proceed Cost of of proceed Use of Fund
Type of Net Remaining
Name of from the Public according to according to
public Listing Date Realization Fund (in
Issuance Public Offering (in the the
offering (in Currency) Currency)
Offering (in Currency) Prospectus Prospectus
Currency) (in Currency) (in Currency)
71,400,000,0 3,256,316,54 68,143,683,4 68,143,683,4 68,143,683,4
IPO Saham LABS 0
00 3 57 57 57
Allocation of Remaining Fund
Type of public Name / Code of
List of allocation
offering Securities
Remaining Fund Interest/Yield Relationship with
Allocation Retention Period
(in Currency) Rate the company
IPO Saham LABS
rekening
14,205,119,400 1.9 % 0 pihak Tiga
operasional
Details of Public Offering Plan
Type of public Name / Code of
Listing date List of plans
offering Securities
Net Realization Amount (in
Description Percentage
(in Currency) Currency)
IPO Saham LABS pembayaran 13.1700000
13,628,736,691 8,977,862,001 %
pinjaman 76293945
pembayaran 23.6800003
16,139,294,459 16,139,294,459 %
supplier lokal 0517578
pembayaran
42.2999992
28,821,407,557 supplier luar 28,821,407,557 %
3706055
negeri
Page 5
Details of Public Offering Realization
Type of Public Name / Code of
Listing Date Realization Plan
Offering Securities
Net Realization Amount (in
Description Percentage
(in Currency) Currency)
IPO Saham LABS pembayaran 19.2299995
68,143,683,457 13,104,531,025 %
pinjaman 42236328
pembayaran 19.9500007
68,143,683,457 13,593,181,744 %
supplier lokal 62939453
pembayaran
60.8199996
68,143,683,457 supplier luar 41,445,970,688 %
9482422
negeri
Details of Cost of Public Offering
Amount of
Type of Public Amount (in Percenta
Securities Code Listing Date Proceed for the Description
Offering Currency) ge
Public Offering
IPO Saham LABS 71,400,000,000a. Underwriting fee
1,600,094,200 2.24 %
b. Management fee
0 0 %
c. Selling fee
0 0 %
d. Capital Market
Supporting Profession
1,120,500,000 1.58 %
fee
e. Capital Market
Supporting Institution fee
370,708,333 0.52 %
f. Financial advisory fee
0 0 %
g. Other fees which can
be directly attributed as
165,014,010 0.23 %
securities issuance fees
Thus to be informed accordingly.
Respectfully,
PT UBC Medical Indonesia Tbk
Franciscus Xaverius Yoshua Raintjung
Page 6
Direktur Utama
PT UBC Medical Indonesia Tbk
Kawasan Industri Pulogadung, Jl. Rawa Gelam V, Blok L, No Kav 11-13, Kel.
Phone : 021-38865110, Fax : , www.ubcindonesia.com
Sender Name Franciscus Xaverius Yoshua Raintjung
Function Direktur Utama
Date and Time 14-01-2026 23:30
Attachment 1. LABS_Laporan Penggunaan Dana IPO 31 Des 2025.pdf
This is an official document of PT UBC Medical Indonesia Tbk that does not require a signature as it was generated
electronically by the electronic reporting system. PT UBC Medical Indonesia Tbk is fully responsible for the
information contained within this document.
Names mentioned 3 people and organisations named in the text · linked when the evidence is strong
unresolved
person
Franciscus Xaverius Yoshua Raintjung
· Direktur Utama
p.2 ×6
unresolved
person
Function
· Direktur Utama
p.6
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.